Additional authors:

Adam Tellier, Rena M. Conti


Abstract:

There is uncertainty regarding which brand-name prescription drugs will have their prices negotiated by Medicare in 2025. This Viewpoint analyzes the process that will be used to select the next 15 drugs for price negotiation.

 

Citations

Vogel, Matthew, Adam Tellier, and Rena M. Conti. 2024. Predicting the next round of drugs for Medicare price negotiation. Science Translational Medicine, Vol. 16, No. 776. Cambridge, MA: Mossavar-Rahmani Center for Business & Government, Harvard Kennedy School. https://www.science.org/doi/pdf/10.1126/scitranslmed.adq5711.